Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Germline TERT promoter mutations are rare in familial melanoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. High accuracy of family history of melanoma in Danish melanoma cases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prevalence of Pathogenic Germline DICER1 Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish Cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Genomforskningsprojekt påviser TP53-mutation hos en pige med rabdomyosarkom

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • SIOPE Host Genome Working Group
Vis graf over relationer

DICER1 syndrome is a rare genetic disorder that predisposes to a wide spectrum of tumors. Developing surveillance protocols for this syndrome is challenging because uncertainty exists about the clinical efficacy of surveillance, and appraisal of potential benefits and harms vary. In addition, there is increasing evidence that germline DICER1 pathogenic variants are associated with lower penetrance for cancer than previously assumed. To address these issues and to harmonize DICER1 syndrome surveillance programs within Europe, the Host Genome Working Group of the European branch of the International Society of Pediatric Oncology (SIOPE HGWG) and Clinical Guideline Working Group of the CanGene-CanVar project in the United Kingdom reviewed current surveillance strategies and evaluated additional relevant literature. Consensus was achieved for a new surveillance protocol and information leaflet that informs patients about potential symptoms of DICER1-associated tumors. The surveillance protocol comprises a minimum program and an extended version for consideration. The key recommendations of the minimum program are: annual clinical examination from birth to age 20 years, six-monthly chest X-ray and renal ultrasound from birth to age 6 years, and thyroid ultrasound every 3 years from age 8 to age 40 years. The surveillance program for consideration comprises additional surveillance procedures, and recommendations for DICER1 pathogenic variant carriers outside the ages of the surveillance interval. Patients have to be supported in choosing the surveillance program that best meets their needs. Prospective evaluation of the efficacy and patient perspectives of proposed surveillance recommendations is required to expand the evidence base for DICER1 surveillance protocols.

OriginalsprogEngelsk
TidsskriftFamilial Cancer
Vol/bind20
Udgave nummer4
Sider (fra-til)337-348
Antal sider12
ISSN1389-9600
DOI
StatusUdgivet - okt. 2021

ID: 67849261